For Immediate Release
Contact: Rob Grant, Communications Director
202.966.7300, Ext. 119
Anna Eisenberg, Communications Coordinator
202.966.7300, Ext. 154
Washington, D.C., October 11, 2010 - The American Academy of Child and Adolescent Psychiatry (AACAP) is pleased to announce Benjamin I. Goldstein, M.D., Ph.D., as the recipient of the Klingenstein Third Generation Foundation Award for Research in Depression or Suicide for his paper, "Substance Use and the Treatment of Resistant Depression in Adolescents."
"This paper represents my third effort at examining the topic of occasional substance use, and prior studies of adults with depression and bipolar disorder yielded similar findings. Thus far, it appears that when it comes to substance use in the context of major mood disorders, a little bit may indeed be too much," said Dr. Goldstein in a written statement.
AACAP's Klingenstein Third Generation Foundation Award for Research in Depression or Suicide is supported by the Klingenstein Third Generation Foundation. The foundation awards grants to major medical institutions for post-doctoral fellowships in child and adolescent ADHD and child and adolescent depression. It also funds medical student programs in child and adolescent psychiatry at select medical institutions.
Dr. Goldstein presents, "Substance Use and the Treatment of Resistant Depression in Adolescents," at AACAP's 57th Annual Meeting, October 28, 2010 in New York, NY.
For more information on this award, please contact Anna Eisenberg, Communications Coordinator, at 202.966.7300, ext. 154 or email@example.com.
Representing over 8,000 child and adolescent psychiatrists nationwide, the American Academy of Child and Adolescent Psychiatry (AACAP) is the leading authority on children's mental health.
AACAP Members actively research, diagnose and treat psychiatric disorders affecting children, adolescents and their families. For more information please visit www.aacap.org.